Recombinant Human bCMO1 Protein，His

BCMO1 (beta-carotene 15,15'-monooxygenase 1) is an enzyme crucial in the conversion of beta-carotene into retinal, a vital component of visual pigments in the retina. The significance of BCMO1 in human health lies in its role in vitamin A metabolism, as beta-carotene is a major dietary precursor of vitamin A. Variability in BCMO1 activity due to genetic polymorphisms can lead to differences in individual responses to beta-carotene intake, impacting vitamin A status and overall health. Research into BCMO1 recombinant proteins has gained traction as scientists aim to elucidate the enzyme’s structure-function relationship, regulatory mechanisms, and interaction with dietary carotenoids. Understanding BCMO1's biochemical pathways is essential for addressing public health issues related to vitamin A deficiency, which remains a significant concern in many parts of the world. Furthermore, studies on BCMO1 may provide insights into its therapeutic potential, as modulating its activity could enhance vitamin A bioavailability from plant sources, offering a dietary strategy for improving health outcomes in populations reliant on carotenoid-rich diets. Through recombinant protein studies, researchers can explore the enzyme's characteristics, assess the impact of polymorphisms, and evaluate potential applications in nutrition and health supplementation, contributing to a deeper understanding of how dietary components influence metabolic processes.